Constitutive activation of Lyn in CLL cells may be the result of chronic BCR engagement, but another proposed explanation is low expression levels of the protein tyrosine phosphatase PTPRO due to epigenetic silencing [97, 98]. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.